MCAM interacts with integrin β1 to promote EGFR-TKI resistance in lung adenocarcinoma through the JAK3 signalling pathway.

Saved in:
Bibliographic Details
Title: MCAM interacts with integrin β1 to promote EGFR-TKI resistance in lung adenocarcinoma through the JAK3 signalling pathway.
Authors: Zhang, Saiqun1,2 (AUTHOR), Chen, Yuling1,2 (AUTHOR), Li, Chang1,2 (AUTHOR), Zhao, Jian1,2 (AUTHOR), Jiao, Min1,2 (AUTHOR), Zhang, Mengzhu1,2 (AUTHOR), Ma, Chenkang1,2 (AUTHOR), Wang, Anqi1,2 (AUTHOR), Li, Jianjun1,2,3 (AUTHOR), Zeng, Yuanyuan1,2,3 (AUTHOR), Zhu, Jianjie1,2,3 (AUTHOR), Mu, Chuanyong1,2,3 (AUTHOR) mcy028@126.com, Huang, Jian-an1,2,3 (AUTHOR) huang_jian_an@163.com, Liu, Zeyi1,2,3,4 (AUTHOR) liuzeyisuda@163.com
Source: Journal of Translational Medicine. 7/25/2025, Vol. 23 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-06874-9